Abbott Laboratories (ABT): Price and Financial Metrics

ABT POWR Grades

• Stability is the dimension where ABT ranks best; there it ranks ahead of 89.27% of US stocks.
• ABT's strongest trending metric is Quality; it's been moving up over the last 179 days.
• ABT ranks lowest in Momentum; there it ranks in the 19th percentile.

ABT Stock Summary

• ABT has a market capitalization of $211,952,933,671 -- more than approximately 98.98% of US stocks.
• ABT's went public 36.27 years ago, making it older than 92.84% of listed US stocks we're tracking.
• In terms of volatility of its share price, ABT is more volatile than only 10.73% of stocks we're observing.
• Stocks that are quantitatively similar to ABT, based on their financial statements, market capitalization, and price volatility, are DHR, TMO, MDT, NKE, and CMCSA.
• Visit ABT's SEC page to see the company's official filings. To visit the company's web site, go to www.abbott.com.

ABT Valuation Summary

• ABT's price/earnings ratio is 35.1; this is 3.84% lower than that of the median Healthcare stock.
• Over the past 243 months, ABT's price/sales ratio has gone up 0.3.
• Over the past 243 months, ABT's price/earnings ratio has gone down 10.1.

Below are key valuation metrics over time for ABT.

ABT Growth Metrics

The 3 year net income to common stockholders growth rate now stands at 7.15%.
• Its 5 year revenue growth rate is now at 57.38%.
• The 5 year net income to common stockholders growth rate now stands at 46.26%.

Over the past 34 months, ABT's revenue has gone up $12,352,000,000.

The table below shows ABT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	43,075	10,533	7,071
2021-09-30	42,308	11,264	7,244
2021-06-30	40,233	10,629	6,376
2021-03-31	37,338	9,823	5,724
2020-12-31	34,608	7,901	4,495
2020-09-30	32,221	6,519	3,382

ABT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ABT has a Quality Grade of B, ranking ahead of 77.76% of graded US stocks.
• ABT's asset turnover comes in at 0.559 -- ranking 70th of 680 Pharmaceutical Products stocks.
• DVAX, RARE, and CORT are the stocks whose asset turnover ratios are most correlated with ABT.

The table below shows ABT's key quality metrics over time.